The prooligonucleotide approach. III: Synthesis and bioreversibility of a chimeric phosphorodithioate prooligonucleotide

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 4, 1996, Pages 457-462

  Tosquellas, Guilhem ^a   Barber, Isabelle ^a   Morvan, François ^a   Rayner, Bernard ^a   Imbach, Jean Louis ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; OLIGONUCLEOTIDE; PRODRUG;

ARTICLE; BIOAVAILABILITY; CONTROLLED STUDY; DRUG METABOLISM; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; STOMACH; SWINE;

EID: 0029924515     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00051-0     Document Type: Article

References (25)

1. Milligan, J. F.; Matteucci, M. D.; Martin, J. C. J. Med. Chem. 1993, 36, 1923.
2. Varma, R. S. Synlett 1993, 621.
3. Uhlmann, E.; Peyman, A. Chem. Rev. 1990, 90, 543.
4. Stein, C. A.; Cheng, Y. C. Science 1993, 261, 1004.
5. Spiller, D. G.; Tidd, D. M. Anti - Cancer Drug Design 1992, 7, 115.
6. Giles, R. V.; Spiller, D. G.; Tidd, D. M. Anti - Cancer Drug Design 1993, 8, 33.
7. Tidd, D. M. Biochemical Society Transactions 1992, 20, 746.
8. Leonetti, J.-P.; Degols, G.; Lebleu, B. Bioconjugate Chemistry 1990, 1, 149.
9. Letsinger, R. L.; Zhang, G.; Sun, D. K.; Ikenchi, T.; Sarin, P. S. Proc. Natl. Acad. Sci. USA 1989, 86, 6553.
10. Akhtar, S.; Juliano, R. L. Journal of Controlled Release 1992, 22, 47.
11. Crooke, S. T. Nucleic Acid Therapeutics in Pharmaceutical Manufacturing International; P. A. Barnacal, Eds.; Sterling Publications Limited: London, 1992; pp 89.
12. Stein, C. A.; Tonkinson, J. L.; Yakubov, L. Pharmacology & Therapeutics 1991, 52, 365.
13. Stein, C. A.; Krieg, A. M. Antisense Res. Dev. 1994, 4, 67.
14. Wagner, R. W. Nature 1994, 372, 333.
15. Barber, I.; Rayner, B.; Imbach, J. L. Bioorganic & Medicinal Chemistry Letters 1995, 5, 563.
16. Barber, I.; Tosquellas, G.; Morvan, F.; Rayner, B.; Imbach, J.-L. Bioorg. Med. Chem. Lett. 1995, 5, 1441.
17. Stawinski, J.; Thelin, M.; Zain, R. Tetrahedron Lett. 1989, 30, 2157.
18. Stawinski, J.; Thelin, M.; Westman, E. J. Org. Chem. 1990, 55, 3503.
19. Belsner, K.; Hoffman, H. M. R. Synthesis 1982, 239.
20. 4, 3a : 96.8 and 97.2, 3b : 97.1 and 97.3, 3c : 96.6 and 97.2.
21. Pompon, A.; Lefebvre, I.; Imbach, J. L. Biochem. Pharmacol. 1992, 43, 1769.
22. Cox, J. R.; Ramsay, B. Chem. Rev. 1964, 64, 317.
23. Berman, H. A.; Leonard, K. J. Biol. Chem. 1989, 264, 3942.
24. Zhao, Q.; Kovach, I. M.; Bencsura, A.; Papathanassiu, A. Biochemistry 1994, 33, 8128.
25. 31P-NMR broad peaks centered at 35.8 and 97.6 ppm for respectively methylphosphonate and thionophosphorothiolate linkages.